Assistant Professor of Radiation Oncology, University Colorado
Radiation Oncology
Dr. Tracey Schefter, MD
|
|
Give Review
Tracey Schefter practices Radiation Oncology. She has 2 awards "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Tracey Schefter is a published doctor and has 40 publications published. The lastest was: 'Practical implementation of quality improvement for high-dose-rate brachytherapy.' Tracey Schefter accepts all Medicare patients.
Publications
- Practical implementation of quality improvement for high-dose-rate brachytherapy.
- Are we appropriately selecting therapy for patients with cervical Cancer? Longitudinal patterns-of-care analysis for stage IB-IIB cervical Cancer.
- Radiation therapy oncology group gynecologic oncology working group: comprehensive results.
- RTOG 0417: Efficacy of Bevacizumab in Combination With Definitive Radiation Therapy and Cisplatin Chemotherapy in Untreated Patients With Locally Advanced Cervical Car...
- Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy.
- Serious Complications Associated with Stereotactic Ablative Radiotherapy and Strategies to Mitigate the Risk.
- Regional Normal Lung Tissue Density Changes in Patients Treated With Stereotactic Body Radiation Therapy for Lung Tumors.
- Evaluation of threshold and gradient based (18)F-fluoro-deoxy-2-glucose hybrid positron emission tomographic image segmentation methods for liver tumor delineation.
- Clinical potential of bevacizumab in the treatment of metastatic and locally advanced cervical Cancer: current evidence.
- The role of postoperative radiation therapy for endometrial Cancer: Executive Summary of an American Society for Radiation Oncology evidence-based guideline.
- Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy.
- How should we describe the radioblologic effect of extracranial stereotactic radlosurgery: equivalent uniform dose or tumor control probability?
- Clinical application of intensity-modulated radiotherapy for locally advanced cervical Cancer.
- Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix Cancer.
- Triple modality (neoadjuvant chemoradiotherapy followed by surgical resection): is it better than definitive chemoradiation therapy in Cancer of the thoracic esophagus?
- Selective internal radiotherapy in metastatic esophageal adenocarcinoma.
- Radiation therapy for liver metastases.
- Esophageal Cancer patients undergoing external beam radiation after placement of self-expandable metal stents: is there a risk of radiation dose enhancement?
- Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control.
- Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis.
- Stereotactic body radiotherapy for early-stage non-small-cell lung Cancer: report of the ASTRO Emerging Technology Committee.
- Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate Cancer: report of the American Society for Therapeutic Radiolo...
- Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma.
- Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.
- Results of a phase I trial of 12 patients with locally advanced pancreatic carcinoma combining gefitinib, paclitaxel, and 3-dimensional conformal radiation: report of ...
- Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
- Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
- Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy.
- Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal Cancer: a surveillance, epidemiology, and end-results study.
- Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal Cancer: a phase II trial.
- Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical Cancer.
- The dosimetric effect of inhomogeneity correction in dynamic conformal arc stereotactic body radiation therapy for lung tumors.
- Interim analysis of a prospective phase I/II trial of SBRT for liver metastases.
- Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy.
- Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, Part 2.
- A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases.
- Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, part 1.
- Stereotactic body radiation therapy. Rationale, techniques, applications, and optimization.
- Ovarian immature teratoma with implants and metastases.
Schools
Queen39s University Kingston Ontario Canada
Conditions Treated
- Vulvar Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Hospital
-
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1609983444 | |
| NPPES Provider LastName | SCHEFTER | |
| NPPES Provider FirstName | TRACEY | |
| NPPES Provider ZIPCode | 800452545 | |
| NPPES Provider State | CO | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 30.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609983444 |
| Last Name Of The Provider | SCHEFTER |
| First Name Of The Provider | TRACEY |
| View All |
Similar Doctors
|
Dr. David Raben, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Rachel Rabinovitch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arthur K. Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian D. Kavanagh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Krishna Reddy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chad G. Rusthoven, MD |